{
  "ptid_time": "068_S_2171_2010-11-09",
  "img_path": "/data/qiuhui/data/adni/images/068_S_2171/2010-11-09/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 11,062 mm³, 50.5% below the reference mean. With a Z-score of -1.26 (10.3th percentile), this represents mild atrophy; hippocampal volume measures 6,494 mm³, 15.5% below the reference mean. With a Z-score of -1.74 (4.1th percentile), this represents moderate atrophy; whole brain volume measures 1,021,380 mm³, 0.8% below the reference mean. With a Z-score of -0.09 (46.3th percentile), this represents normal volume ; entorhinal cortex volume measures 3,510 mm³, 9.8% below the reference mean. With a Z-score of -0.76 (22.3th percentile), this represents normal volume ; fusiform gyrus volume measures 16,049 mm³, 11.9% below the reference mean. With a Z-score of -1.34 (9.1th percentile), this represents mild atrophy; middle temporal gyrus volume measures 16,121 mm³, 21.4% below the reference mean. With a Z-score of -1.91 (2.8th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 65.3 years. Gender is Female. Education: 10 years. Handedness: Right. Race: White. Medical history: Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Major Surgical Procedures. MMSE: 28.0. MoCA: 17.0. Logical Memory: 6.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.56 SUVR (profound elevated); Amyloid beta: 738.20 pg/mL (normal ); Total tau: 350.70 pg/mL (mild elevated); Phosphorylated tau: 42.04 pg/mL (significant elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows moderate hippocampal atrophy (Z-score -1.74, 4.1th percentile) and mild-to-moderate atrophy in other temporo-limbic regions (fusiform gyrus, middle temporal gyrus), which is concerning for neurodegeneration. The MoCA score of 17 (below the typical cutoff of 26) suggests cognitive impairment, while the MMSE of 28 is less sensitive. Biomarkers indicate significant amyloid pathology (AV45 PET \"profound elevated\") and tauopathy (elevated P-tau), supporting Alzheimer’s pathophysiology despite normal Aβ (possibly due to assay limitations).  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease)**  \n**Confidence:** **High**  \n\n*(Key findings: MoCA 17 + temporo-limbic atrophy + amyloid/tau biomarkers. Normal Aβ is atypical but may reflect technical/assay variance; the overall profile is strongly AD-consistent.)*",
  "timestamp": "2025-07-26T08:53:23.362523"
}